WHO-GMP sourced EU-GMP partners ISO 9001:2015 49+ export markets Since 2003

Where we ship from Mumbai.

Forty-eight-plus countries, eight regions, one operational discipline. M Care Exports runs each of these desks from Mumbai. Our market reach is built around the regulators we actually know, MHRA, ANSM, BfArM, SFDA, MOHAP, EDA, JFDA, ANVISA, COFEPRIS, INVIMA, ISP, DIGEMID, DAV, Thai FDA, NPRA, DGDA, NMRA, DDA, NAFDAC, PPB, TMDA, NDA, SAHPRA, EFDA, ANARME, ACOREP, AIRP, ARP, DPML, DMP, NCEMM, UzPharm, AGEMA, DLS, PFDA, not a list of pins on a map.

WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners ISO 9001:2015 SGS GDP Certified Pharmexcil RCMC FIEO Member Cold-chain validated CTD / eCTD ready
United Kingdom & Europe

Regulated, predictable, paperwork-heavy.

Our London desk handles UK and European accounts, MHRA, ANSM and BfArM liaison, Specials and named-patient routes, French-language labelling for ANSM, and the procurement paperwork that defines NHS, AP-HP and UniHA supply.

Gulf Cooperation Council

GCC, our Dubai team's home turf.

Dedicated desks for SFDA, MOHAP, DHA, the Gulf Health Council, and the tender desks that run Gulf public-sector procurement. Bonded warehousing available for JAFZA and DAFZA operations.

Middle East & North Africa

MENA, beyond the GCC.

Egypt's EDA is the largest Africa pharma market; Jordan's JFDA sits adjacent to the GCC recognition net; Iraq runs two tracks, federal Kimadia and the Kurdistan Region MOH; Morocco's DMP and Tanger Med anchor Maghreb commerce; Tunisia's PCT runs an institutional import monopoly. French and Arabic dossier capability where the regulator demands it; tender-aware commercial schedules on every file.

South Asia

The shortest international lanes we run.

Sri Lanka and Nepal are the two markets where India is structurally the dominant pharmaceutical source, where bilateral recognition between CDSCO and the destination regulator runs faster than any other corridor, and where INR or LKR settlement removes the FX-exposure friction that complicates every other Asian lane. Mumbai-Colombo is short-haul air, Mumbai-Birgunj is overland road; documentation written in CTD and English clears on first pass.

Southeast Asia

ASEAN, ACTD-aligned filings.

Our Singapore desk handles ASEAN-wide regulatory coordination and ACTD-harmonised dossier preparation. Vietnamese DAV filings, Thai FDA and GPO tenders, Malaysian NPRA + Pharmaniaga state-channel supply (with halal certification where the dosage form requires it), Philippine FDA filings, DOH and PhilHealth tender response, and Mercury Drug retail channel support from Manila to Cebu.

Latin America

LATAM, Spanish-CTD documentation, public-private dual channels.

Three Andean and Caribbean-Pacific markets where Indian generic pharmaceuticals have material share against the Spanish-language regulatory cost. Peru runs CENARES tenders alongside EsSalud social-security procurement; Chile is the most reliable LATAM payment counterparty with CENABAST as the single state buyer; Colombia's INVIMA reform and 2024 oncology procurement reset opened space for biosimilar competition that aligns with M Care's oncology strength.

Eurasia

Russian-language CTD, single-buyer tender desks, sanctions-clean USD.

Four lanes that share one commercial shape: a central state buyer, a Russian-language dossier, and USD invoicing that carries no sanctions exposure despite EAEU adjacency. Kazakhstan runs SK-Pharmacy, among the most concentrated public pharmaceutical procurement structures anywhere, on NCEMM filings. Uzbekistan has been hard-currency convertible since the 2017 reforms, files through UzPharm, and now ranks top-three for Indian pharmaceutical exports. Azerbaijan consolidated state-hospital demand into TƏBIB LLC in 2019, on AGEMA-aligned dossiers with BOM-GYD freight via Doha or Istanbul. Ukraine buys through three parallel channels: UN and Crown Agents donor procurement, the open ProZorro e-tender platform, and direct private-hospital purchasing, on validated overland-via-Poland cold-chain routing from Mumbai. All four support INR settlement through the bilateral SBI arrangements.

Your market not listed?

Ad-hoc enquiries from outside the forty-eight.

The forty-eight countries above are the markets where we have dedicated desks and repeat-order tender relationships. We also take ad-hoc enquiries from outside that list on a case-by-case basis, named-patient imports, NGO procurements, one-off tender bids. Send us your brief and we'll confirm whether we can route it.

Ask about your market